A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment
for Noonan Syndrome
22 locations incl. Los Angeles
Sponsor: BioMarin Pharmaceutical
Sex: All·Age: 3 - 11
Code: NCT06668805·Phase 2·Recruiting·Listed Oct 2024